GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) » Definitions » Total Inventories

Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Total Inventories : ¥90.4 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Chengdu Olymvax Biopharmaceuticals Total Inventories?

Chengdu Olymvax Biopharmaceuticals's total inventories for the quarter that ended in Sep. 2024 was ¥90.4 Mil. Chengdu Olymvax Biopharmaceuticals's average total inventories from the quarter that ended in Jun. 2024 to the quarter that ended in Sep. 2024 was ¥87.9 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Chengdu Olymvax Biopharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was ¥-0.21.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Chengdu Olymvax Biopharmaceuticals's Days Inventory for the three months ended in Sep. 2024 was 987.66.

Inventory Turnover measures how fast the company turns over its inventory within a year. Chengdu Olymvax Biopharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.09.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Chengdu Olymvax Biopharmaceuticals's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.55.


Chengdu Olymvax Biopharmaceuticals Total Inventories Historical Data

The historical data trend for Chengdu Olymvax Biopharmaceuticals's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Olymvax Biopharmaceuticals Total Inventories Chart

Chengdu Olymvax Biopharmaceuticals Annual Data
Trend Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Inventories
Get a 7-Day Free Trial Premium Member Only 33.93 46.00 74.50 78.52 72.12

Chengdu Olymvax Biopharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.78 72.12 76.67 85.38 90.44

Chengdu Olymvax Biopharmaceuticals Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Chengdu Olymvax Biopharmaceuticals  (SHSE:688319) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Chengdu Olymvax Biopharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is

Net-Net Working Capital Per Share (Q: Sep. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(269.461+0.75 * 528.396+0.5 * 90.441-786.627
-0-9.751)/405.934
=-0.21

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Chengdu Olymvax Biopharmaceuticals's Days Inventory for the three months ended in Sep. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2024 )/Cost of Goods Sold (Q: Sep. 2024 )*Days in Period
=87.91/8.122*365 / 4
=987.66

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Chengdu Olymvax Biopharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2024 ) / Average Total Inventories (Q: Sep. 2024 )
=8.122 / 87.91
=0.09

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Chengdu Olymvax Biopharmaceuticals's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=87.91 / 160.369
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Chengdu Olymvax Biopharmaceuticals Total Inventories Related Terms

Thank you for viewing the detailed overview of Chengdu Olymvax Biopharmaceuticals's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Olymvax Biopharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
99 Tianxin Road, High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.
Executives
Li Hong Guang Core technical personnel
Fan Shao Wen Directors, senior managers
Ma Heng Jun senior management
Wu Wei senior management
Fan Fan Director
Chen Ai Min Director
Tan Yong senior management
Lu Lu Director
Yu Yun Hui Director
Chen Dao Yuan Core technical personnel
Zhang Li Ying Core technical personnel
Chen Ke Ping Core technical personnel
Wu Qiang Core technical personnel
Yang Feng Core technical personnel

Chengdu Olymvax Biopharmaceuticals Headlines

No Headlines